1 | 4-Aminobenzoic acid [PABA] | 5 per cent | — | — |
2 | N,N,N-Trimethyl-4-(2-oxoborn-3-ylidenemethyl)anilinium methyl sulphate [Camphor benzalkonium methosulfate] | 6 per cent | — | — |
3 | Homosalate (INN) | 10 per cent | — | — |
4 | Oxybenzone (INN)
[Benzophenone-3]
| 10 per cent | — | Contains oxybenzone. (Not required when concentration is not more than 0.5 per cent, and when the substance is only intended to protect the product) |
5 | ENTRY DELETED | | | |
6 | 2-Phenylbenzimidazole-5-sulphonic acid [Phenylbenzimidazole sulfonic acid] and its potassium, sodium and triethanolamine salts | 8 per cent (expressed as acid) | — | — |
7 | 3,3-(1,4-Phenylenedimethylene)bis(7,7-dimethyl-2-oxo-bicyclo[2.2.1]hept-1-ylmethanesulfonic acid) [Terephthalylidene dicamphor sulfonic acid] and its salts | 10 per cent (expressed as acid) | — | — |
8 | 1-(4-tert-Butylphenyl)-3-(4-methoxyphenyl)-propane-1,3-dione (Avobenzone (INN))
[Butyl methoxy dibenzoylmethane]
| 5 per cent | — | — |
9 | α-(2-Oxoborn-3-ylidine)toluene-4-sulphonic acid [Benzylidene camphor sulfonic acid] and its salts | 6 per cent (expressed as acid) | — | — |
10 | 2-Ethylhexyl 2-cyano-3,3-diphenylacrylate [Octocrylene] | 10 per cent (expressed as acid) | — | — |
11 | Polymer of N-[(2 and 4)-[2-oxoborn-3-ylidene)methyl]benzyl]acrylamide
Polyacrylamidomethyl benzylidene camphor]
| 6 per cent | — | — |
12 | 2-Ethylhexyl 4-methoxycinnamate
[Octyl methoxycinnamate]
| 10 per cent | — | — |
13 | Ethoxylated ethyl-4-aminobenzoate
[PEG-25 PABA]
| 10 per cent | — | — |
14 | Isopentyl 4-methoxycinnamate
[Isoamyl p-methoxycinnamate]
| 10 per cent | — | — |
15 | Tris(2-ethylhexyl) 4,4’4”-(1,3,5-triazine-2,4,6-triyltriimino)tribenzoate
[Octyl triazone]
| 5 per cent | — | — |
16 | 2-(2H-Benzotriazol-2-yl)-4-methyl-6-[2-methyl-3-[1,3,3,3-tetramethyl-l-(trimethylsilyloxy)-disiloxan-1-yl]propyl]phenol
[Drometrizole trisiloxane]
| 15 per cent | — | — |
17 | Bis(2-ethylhexyl) 4,4’-[6-tert-butylcarbamoylanilino)-1,3,5-triazine-2,4-diyldiimino]dibenzoate | 10 per cent | — | — |
18 | 3-(4-Methylbenzylidine)bornan-2-one
[4-Methylbenzylidene camphor]
| 4 per cent | — | — |
19 | 3-Benzylodenebornan-2-one
[3-Benzylidene camphor
| 2 per cent | — | — |
20 | 2-Ethylhexyl salicylate
[Octyl salicylate]
| 5 per cent | — | — |
21 | 2-Ethylhexyl 4-dimethylaminobenzoate
[Octyl dimethyl PABA]
| 8 per cent | — | — |
22 | 2-Hydroxy-4-methoxybenzophenone-5-sulfonic acid [Benzophenone-4] and its sodium salt [Benzophenone-5] (Sulisobenzone (INN) and Sulisobenzone sodium (INNM)) | 5 per cent (expressed as acid) | — | — |
23 | 2-2’-Methylenebis[6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol] | 10 per cent | — | — |
24 | diSodium 2,2’-(1,4-phenylene)bis(lH-benzimidazole-4,6-disulfonate) | 10 per cent (expressed as acid) | — | — |
25 | 5,5’-Bis(2-ethylhexyloxy)-2,2’-(6-p-methoxyphenyl-1,3,5-triazine-2, 4-diyl)diphenol | 10 per cent | — | — |
26 | α-(Trimethylsilyl)-w-(trimethylsilyloxy)poly-[oxy(dimethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl]phenoxy]-1-methyleneethyl)silylene]-co-[oxy(methyl)(2-[p-[2,2-bis(ethoxycarbonyl)vinyl)]phenoxy]prop-1-enyl)silylene] where there are usually 60 polymeric units, of which the first part of the copolymer provides 56 (Dimethicodiethylbenzyalmalonate)
(CAS No. 207574-74-1)
| 10 per cent | — | — |
27 | Titanium dioxide | 25 per cent | — | — |